secwatch / observer
8-K filed April 11, 2025, 7:59 PM ET ticker EVCM CIK 0001853145
regulatory confidence high sentiment neutral materiality 0.35

EverCommerce Inc. (EVCM): Nasdaq/NYSE listing notice — EverCommerce board resignation causes Nasdaq Audit Committee non-compliance

EverCommerce Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alexi Wellman

Director
EVCM · EverCommerce Inc.
Effective
2025-04-10
Filed
April 11, 2025, 7:59 PM ET
the effectiveness of Ms. Wellman’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

EverCommerce Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).

Exchange
nasdaq
Notice
noncompliance notice
Deficiency
audit committee
Rules
5605(c)(2)(A), 5605(c)(4)(B)
Exact text from the filing
April 11, 2025, the Company notified Nasdaq of its non-compliance with Nasdaq Rule 5605(c)(2)(A) as a result of the Vacancy and its intent to rely on the cure period provided to the Company by Nasdaq Rule 5605(c)(4)(B). The Company intends to appoint to the Audit Committee a third director who satisfies the criteria for service on the Audit Committee no later than 180 days after the effectiveness of Ms. Wellman’s resignation.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Alexi Wellman resigned as Director at EverCommerce Inc..

Action
resigned
Role
Director
Exact text from the filing
the effectiveness of Ms. Wellman’s resignation.
View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

EverCommerce Inc. filing history →

Source: SEC EDGAR
accession 0001140361-25-013496
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.